TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ALXO

Alx Oncology Holdings 

Healthcare · Biotechnology

1.20$ -6.2% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ALXO
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– +132.0% -75.4% -100.0% – – – –
– +131.9% -75.3% -31.5% +99.2% -43.0% +4.3% –
– +133.2% -75.5% -787.9% – – – –
– +44.7% +77.6% +107.8% +63.5% +44.1% -17.9% -33.8%
– +27.4% +347.0% +57.9% +24.2% -1.9% -8.4% -8.6%
– +41.4% +123.1% +90.9% +52.5% +33.6% -16.3% -27.0%
– – – – – – – –
– – +3,761.9% -98.4% +33,438.5% -64.1% +10.5% -7.3%
– – – – – – – –
– -24.4% +608.8% -108.7% – – – –
– – – – – – – –
– – – – – – – –

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?